{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:17:02Z","timestamp":1792685822357,"version":"4.5.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Individuals with diabetes commonly experience Alzheimer disease and related dementias (ADRD). Factors such as hypoglycemia, hyperglycemia, and glycemic variability have been associated with increased risk of ADRD. Traditional glycemic measures, such as mean glycated hemoglobin A1c<\/jats:sub> (HbA1c<\/jats:sub>), may not identify the dynamic and complex pathophysiologic factors in the association between diabetes and ADRD. The HbA1c<\/jats:sub> time in range (TIR) is a previously developed measure of glycemic control that expresses HbA1c<\/jats:sub> stability over time within specific ranges. This measure may inform the current understanding of the association between glucose levels over time and ADRD incidence.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine the association between HbA1c<\/jats:sub> TIR and incidence of ADRD in older veterans with diabetes.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>The study sample for this cohort study was obtained from administrative and health care utilization data from the Veterans Health Administration and Medicare from January 1, 2004, to December 31, 2018. Veterans 65 years or older with diabetes were assessed. Participants were required to have at least 4 HbA1c<\/jats:sub> tests during the 3-year baseline period, which could start between January 1, 2005, and December 31, 2014. Data analysis was conducted between July and December 2023.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Hemoglobin A1c<\/jats:sub> TIR was calculated as the percentage of days during baseline in which HbA1c<\/jats:sub> was in individualized target ranges based on clinical characteristics and life expectancy, with higher HbA1c<\/jats:sub> TIR viewed as more favorable. The association between HbA1c<\/jats:sub> TIR and ADRD incidence was estimated. Additional models considered ADRD incidence in participants who were above or below HbA1c<\/jats:sub> target ranges most of the time.<\/jats:p><\/jats:sec>Results<\/jats:title>The study included 374\u202f021 veterans with diabetes (mean [SD] age, 73.2 [5.8] years; 369\u202f059 [99%] male). During follow-up of up to 10 years, 41\u202f424 (11%) developed ADRD. Adjusted Cox proportional hazards regression models showed that lower HbA1c<\/jats:sub> TIR was associated with increased risk of incident ADRD (HbA1c<\/jats:sub> TIR of 0 to &amp;lt;20% compared with \u226580%: hazard ratio, 1.19; 95% CI, 1.16-1.23). Furthermore, the direction of out-of-range HbA1c<\/jats:sub> levels was associated with incident ADRD. Having greater time below range (\u226560%, compared with \u226560% TIR) was associated with significantly increased risk (hazard ratio, 1.23; 95% CI, 1.19-1.27). Findings remained significant after excluding individuals with baseline use of medications associated with hypoglycemia risk (ie, insulin and sulfonylureas) or with hypoglycemia events.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study of older adults with diabetes, increased HbA1c<\/jats:sub> stability within patient-specific target ranges was associated with a lower risk of ADRD. Lower HbA1c<\/jats:sub> TIR may identify patients at increased risk of ADRD.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.25354","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T15:34:43Z","timestamp":1722612883000},"page":"e2425354","source":"Crossref","is-referenced-by-count":16,"title":["Glycated Hemoglobin A1c<\/sub> Time in Range and Dementia in Older Adults With Diabetes"],"prefix":"10.1001","volume":"7","author":[{"given":"Patricia C.","family":"Underwood","sequence":"first","affiliation":[{"name":"William F. Connell School of Nursing, Boston College, Boston, Massachusetts"},{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Healthcare Organization & Implementation Research, Veterans Affairs, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Mohr","sequence":"additional","affiliation":[{"name":"National Center for Organizational Development, Veterans Health Administration, Cincinnati, Ohio"},{"name":"Department of Health Law, Policy, and Management, School of Public Health, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Prentice","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah Health, Salt Lake City"},{"name":"Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Budson","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"},{"name":"National Center for Organizational Development, Veterans Health Administration, Cincinnati, Ohio"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Conlin","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"},{"name":"Boston University School of Medicine, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"1","key":"zoi240794r1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review.","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol"},{"issue":"9","key":"zoi240794r2","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study.","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"zoi240794r3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamaneurol.2023.0697","article-title":"Glycemic control over multiple decades and dementia risk in people with type 2 diabetes.","volume":"80","author":"Moran","year":"2023","journal-title":"JAMA Neurol"},{"issue":"7","key":"zoi240794r4","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2337\/dc20-2850","article-title":"Glycemic control, diabetic complications, and risk of dementia in patients with diabetes: results from a large U.K. cohort study.","volume":"44","author":"Zheng","year":"2021","journal-title":"Diabetes Care"},{"issue":"15","key":"zoi240794r5","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2009.460","article-title":"Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.","volume":"301","author":"Whitmer","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"zoi240794r6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4093\/dmj.2021.0346","article-title":"Fasting glucose variability and the risk of dementia in individuals with diabetes: a nationwide cohort study.","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"key":"zoi240794r7","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7706330","article-title":"HbA1c variability and the risk of dementia in patients with diabetes: a meta-analysis.","volume":"2022","author":"Song","year":"2022","journal-title":"Int J Clin Pract"},{"key":"zoi240794r8","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"6. Glycemic targets: Standards of Care in Diabetes\u20142023.","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"10","key":"zoi240794r9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.eprac.2022.08.002","article-title":"American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan\u20142022 update.","volume":"28","author":"Blonde","year":"2022","journal-title":"Endocr Pract"},{"issue":"9","key":"zoi240794r10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.7326\/M17-1362","article-title":"Synopsis of the 2017 U.S. Department of Veterans Affairs\/U.S. Department of Defense clinical practice guideline: management of type 2 diabetes mellitus.","volume":"167","author":"Conlin","year":"2017","journal-title":"Ann Intern Med"},{"key":"zoi240794r11","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.2337\/dc23-S003","article-title":"3. Prevention or delay of type 2 diabetes and associated comorbidities: Standards of Care in Diabetes\u20142023.","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"zoi240794r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002738","article-title":"Association of hemoglobin A1c time in range with risk for diabetes complications.","volume":"10","author":"Mohr","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"12","key":"zoi240794r13","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.2337\/db13-1093","article-title":"Diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.","volume":"62","author":"Nathan","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"zoi240794r14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011295","article-title":"Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults.","volume":"8","author":"Raghavan","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"zoi240794r15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia.","volume":"369","author":"Crane","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi240794r16","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/gerona\/glab221","article-title":"Influence of diabetes duration and glycemic control on dementia: a cohort study.","volume":"76","author":"Li","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi240794r17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jcjd.2015.09.006","article-title":"Diabetes, dementia and hypoglycemia.","volume":"40","author":"Meneilly","year":"2016","journal-title":"Can J Diabetes"},{"issue":"14","key":"zoi240794r18","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/jamainternmed.2013.6176","article-title":"Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus.","volume":"173","author":"Yaffe","year":"2013","journal-title":"JAMA Intern Med"},{"key":"zoi240794r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110085","article-title":"Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: a systematic review and meta-analysis of cohort studies.","volume":"192","author":"Chen","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"zoi240794r20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003211","article-title":"Association of hemoglobin A1c stability with mortality and diabetes complications in older adults with diabetes.","volume":"11","author":"Conlin","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"8","key":"zoi240794r21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2337\/dc21-0292","article-title":"Increased hemoglobin A1c time in range reduces adverse health outcomes in older adults with diabetes.","volume":"44","author":"Prentice","year":"2021","journal-title":"Diabetes Care"},{"issue":"12","key":"zoi240794r22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/dme.2016.33.issue-12","article-title":"Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes.","volume":"33","author":"Prentice","year":"2016","journal-title":"Diabet Med"},{"key":"zoi240794r23","doi-asserted-by":"publisher","first-page":"B10","DOI":"10.2337\/diacare.27.suppl_2.B10","article-title":"Who has diabetes? best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data.","volume":"27","author":"Miller","year":"2004","journal-title":"Diabetes Care"},{"issue":"8","key":"zoi240794r24","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.2337\/dc19-1870","article-title":"Predicting 5- and 10-year mortality risk in older adults with diabetes.","volume":"43","author":"Griffith","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi240794r25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"zoi240794r26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jdiacomp.2017.02.018","article-title":"Diabetes Complications Severity Index (DCSI)\u2014update and ICD-10 translation.","volume":"31","author":"Glasheen","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"8","key":"zoi240794r27","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jalz.2018.02.016","article-title":"Identifying dementia cases with routinely collected health data: a systematic review.","volume":"14","author":"Wilkinson","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"9","key":"zoi240794r28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","article-title":"Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans.","volume":"75","author":"Barnes","year":"2018","journal-title":"JAMA Neurol"},{"issue":"12","key":"zoi240794r29","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1111\/jgs.v71.12","article-title":"Glycemic control and diabetes complications across health status categories in older adults treated with insulin or insulin secretagogues: the Diabetes & Aging Study.","volume":"71","author":"Lipska","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi240794r30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001797","article-title":"Association between hemoglobin A1c variability and hypoglycemia-related hospitalizations in veterans with diabetes mellitus.","volume":"9","author":"Zhao","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"zoi240794r31","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241247568","article-title":"Glucose targets using continuous glucose monitoring metrics in older adults with diabetes: are we there yet?","author":"Toschi","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"zoi240794r32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/joim.2012.273.issue-1","article-title":"Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study.","volume":"273","author":"Lin","year":"2013","journal-title":"J Intern Med"},{"issue":"1","key":"zoi240794r33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13098-022-00799-9","article-title":"Association between hypoglycemia and dementia in patients with diabetes: a systematic review and meta-analysis of 1.4 million patients.","volume":"14","author":"Huang","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"zoi240794r34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3233\/JAD-215153","article-title":"Diabetes mellitus, elevated hemoglobin A1c, and glycated albumin are associated with the presence of all-cause dementia and alzheimer\u2019s disease: the JPSC-AD Study.","volume":"85","author":"Noguchi-Shinohara","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"18","key":"zoi240794r35","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1212\/WNL.0000000000004586","article-title":"Metformin vs sulfonylurea use and risk of dementia in US veterans aged =65 years with diabetes.","volume":"89","author":"Orkaby","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"zoi240794r36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-002894","article-title":"Use of oral diabetes medications and the risk of incident dementia in US veterans aged =60 years with type 2 diabetes.","volume":"10","author":"Tang","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"zoi240794r37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/ageing\/afz108","article-title":"Higher dementia incidence in older adults with type 2 diabetes and large reduction in HbA1c.","volume":"48","author":"Lee","year":"2019","journal-title":"Age Ageing"},{"issue":"9833","key":"zoi240794r38","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction.","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"zoi240794r39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/dme.1993.10.issue-6","article-title":"Recurrent severe hypoglycaemia and cognitive function in type 1 diabetes.","volume":"10","author":"Gold","year":"1993","journal-title":"Diabet Med"},{"issue":"8","key":"zoi240794r40","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/archgenpsychiatry.2009.86","article-title":"Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.","volume":"66","author":"Lyoo","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"zoi240794r41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2215\/CJN.10020620","article-title":"Source of post-transplant care and mortality among kidney transplant recipients dually enrolled in VA and Medicare.","volume":"16","author":"Cashion","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"zoi240794r42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers.","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol"},{"issue":"7","key":"zoi240794r43","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.v39.7","article-title":"Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: a systematic review and network meta-analysis.","volume":"39","author":"Tian","year":"2023","journal-title":"Diabetes Metab Res Rev"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2821878\/underwood_2024_oi_240794_1721926257.04106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T15:34:59Z","timestamp":1722612899000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2821878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.25354","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}